AstraZeneca-University of Cambridge (2025) Project advertisements

The following projects have been selected for the AstraZeneca Funded Non-Clinical PhD Studentships starting 2025. If you are a prospective student please look at the adverts provided below.

UCAM-Supervisor                               

UCAM Department                                               

AZ-Supervisor                       Project Title                                                                                  
Prof. David Bulmer 
PharmacologyFraser WelshHow does the microbiota contribute to chronic pain
Prof. David SpringChemistryJonathan BarghDeveloping the next generation of antibody-oligonucleotide conjugates using divinylpyridimidine conjugation
Prof. Emma RawlinsGurdon/PDNLuigi AloiaA reproducible human lung organoid platform for large scale oncology CRISPR screens
Prof. Ferdia GallagherRadiologyRichard GoodwinMultimodal and multiscale imaging: interrogating renal morphology and function across the disease landscape
Prof. Hugh RobinsonPhysiology, Development and Neuroscience (PDN)Philipe MendoncaUncovering the electrophysiological fingerprints of neuroendocrine cancer cells
Prof. Laura Torrente-MurcianoChemical Engineering & BiotechnologyWill GoundryAccelerating big data in material crystallization
Prof. Matthew GauntChemistryHenry BlackwellRapid development of new catalytic synthetic methodology for fragment-based drug discovery enabled by high-throughput experimentation
Prof. Ravindra GuptaMedicineDaniele CorridoniInteraction between innate immune activation and cell cycle status in macrophages: implications for inflammatory diseases
Prof. Roisin OwensChemical Engineering and BiotechnologyMuireann CoenConformal electronic devices for non-invasive, dynamic monitoring of barrier tissues
Prof. Samuel LambertVictor Phillip Dahdaleh Heart and Lung Research Institute, Department of Public Health & Primary CareXiao JiangPartitioning the effects of high body mass index on risk of future comorbidities.
Prof. Walid KhaledPharmacology/ Cambridge Stem Cell InstituteMark Albertella

Therapeutic cancer prevention of hereditary cancers